Dopamine Index

Running

How much detail do you want?

In plain English

Running is often said to “boost dopamine”, but the one direct human brain scan test of that claim found nothing. Thirty minutes of treadmill running did not measurably change dopamine in healthy volunteers. The good feeling some runners describe, the “runner’s high”, has been tested directly and traced to a completely different brain chemical, not dopamine. Rodent studies do show real dopamine changes with regular exercise, but that has not yet been confirmed in people.

The evidence

Evidence
CC — Limited
Human evidence
Limited · One null PET study in healthy adults; the one positive finding is in Parkinson’s patients.
Studies reviewed
4
Verdict
Explainer — no single claim judged
How sure are we?
Uncertain
Last reviewed
Grade status
Provisional — awaiting editorial validation

Short answer

Running is widely described as a natural dopamine boost and the source of the “runner’s high”, but direct human evidence for a dopamine rise from running specifically is thin. The one PET study that measured brain dopamine before and after 30 minutes of treadmill running in healthy adults found no significant change. The runner’s high itself has been linked experimentally to endocannabinoids, not dopamine or endorphins. A small imaging study in habitual exercisers with Parkinson’s disease did find greater dopamine release after exercise than in sedentary patients.

Evidence
CEvidence grade C · Limited or observational human evidence
Why this grade
The only direct human PET measurement of dopamine release from treadmill running in healthy adults found no significant change 1; the sole positive human finding is a small exercise-and-PET study conducted in Parkinson’s patients rather than healthy runners 2, so overall human dopamine evidence for running specifically is limited.
Last reviewed
24 September 2026

The quick explanation

Running is often talked about as though it reliably “boosts dopamine”, partly because exercise clearly improves mood in many people and partly because rodent studies show real exercise-related changes in dopamine circuits. The direct human test of this, however, gave a flat result: PET scans before and after 30 minutes of treadmill running in healthy volunteers showed no significant change in striatal dopamine. The well-known “runner’s high” — the euphoric, calm feeling some runners describe — has been tested directly against two candidate chemicals, and the evidence points to endocannabinoids rather than dopamine or the classic “endorphin” explanation.

What it is

Running is a form of sustained aerobic exercise, studied here specifically for its effect on the brain’s dopamine system rather than its wider, well-established cardiovascular and mental-health benefits.

Does dopamine play a role?

Dopamine circuits are involved in exercise more broadly — in animal studies, and in some human exercise-and-reward research — but the direct evidence that a session of running itself raises measurable brain dopamine in a healthy person is currently thin, and the running-specific human PET test found no such change.

Human evidence

Direct human evidence that running itself raises brain dopamine is limited, and the one study that tested it cleanly found nothing. Twelve healthy adults with a history of regular exercise had PET scans with the tracer [11C]raclopride, once at rest and once 5–10 minutes after 30 minutes of treadmill running that raised their heart rate by an average of 143%. Dopamine D2 receptor availability in the putamen — the standard PET marker used to infer changes in synaptic dopamine — was essentially unchanged: 4.22 after running versus 4.17 at baseline, not a statistically significant difference.1

Read that result carefully

A null PET result in 12 people does not prove running has no effect on dopamine — it means this particular study, at this intensity and duration, did not detect one. It is still the most direct human test available, and it does not support the common claim that a run reliably “spikes” dopamine.1

The one positive human finding comes from a different population entirely. In a small PET and fMRI study, 8 people with Parkinson’s disease who exercised habitually showed greater dopamine release in the caudate nucleus after a session of stationary cycling than 9 sedentary patients with the same disease, and also showed lower apathy and bradykinesia scores.2 This is genuinely interesting, but it comes from people with a disease that specifically affects dopamine neurons, tested on a stationary bike rather than by running, in a sample of 17 people total — not evidence that a healthy person’s run works the same way.

What about the runner’s high?

The “runner’s high” — a feeling of euphoria and calm during or after sustained exercise — is commonly attributed to dopamine or to “endorphins” in popular writing. A randomised, double-blind, placebo-controlled trial tested this directly by blocking opioid receptors with naltrexone in 63 participants before either running or walking on a treadmill. Running increased euphoria and reduced anxiety compared with walking, and running raised plasma levels of the endocannabinoids anandamide and 2-arachidonoylglycerol. Critically, blocking opioid receptors did not prevent the euphoria, the anxiety reduction, or the endocannabinoid rise — and a comparable proportion of people reported a runner’s high whether or not their opioid receptors were blocked.3 The authors’ own reading is that the runner’s high depends on endocannabinoid signalling, not on opioids — and dopamine was not the mechanism under test at all.

Animal evidence

Rodent studies, reviewed in depth elsewhere, describe voluntary and forced exercise producing real and lasting changes in dopamine circuits — what one review terms a sensitised, “hyperdopaminergic” state in the striatum, in which dopamine release to later, non-exercise stimuli (including things that would normally be experienced as aversive or stressful) becomes exaggerated.4 The same review proposes that this shifts which type of striatal neuron responds to stress — towards a subtype linked to resilience rather than one linked to aversion and vulnerability.4

Why this does not settle the human question

This is a narrative review synthesising rodent data on adaptations that build up with repeated exercise over time, not a single controlled experiment, and it is entirely an animal-model account. It is a plausible mechanism for why regular exercise might eventually reshape dopamine circuits in humans too, but it has not been demonstrated with PET in healthy human runners, and the one PET study that tried, described above, found no acute effect after a single run.4

Mechanism

The proposed rodent mechanism runs through repeated, cumulative exposure: regular voluntary exercise is thought to gradually sensitise mesolimbic and nigrostriatal dopamine pathways, shifting the balance of activity between D1 and D2 receptor-expressing neurons in the striatum in a way that favours resilience to stress.4 If a comparable process occurs in humans, it would be expected to build up gradually with sustained regular exercise rather than appear after a single session — which fits the pattern seen so far: no acute change after one 30-minute run in healthy adults {wang00}, but a positive finding after regular, sustained exercise in a small sample of habitual exercisers with a dopamine-related disease {sacheli18}. That is a plausible but unproven bridge, not an established human mechanism.

This does not mean running has no effect on mood or the brain — the endocannabinoid finding above is itself a real, positive, human result for a different neurochemical system, and running’s broader mental-health effects are covered separately on dopamine and depression. It means specifically that the popular “running boosts your dopamine” claim is currently better supported in rodents than in people.

Evidence strength

The only direct human PET measurement of dopamine release from treadmill running in healthy adults found no significant change 1; the sole positive human finding is a small exercise-and-PET study conducted in Parkinson’s patients rather than healthy runners 2, so overall human dopamine evidence for running specifically is limited.

Common claims

What people sayWhat the evidence says
Running gives your brain a dopamine boostNot shown in the one direct human PET test
The runner’s high is a dopamine rushEvidence points to endocannabinoids instead
Regular runners release more dopamine when they exerciseSuggestive only, and only tested in Parkinson’s patients

What the evidence supports

  • Habitual exercisers with Parkinson’s disease showed greater PET-measured dopamine release in the caudate nucleus after a bout of stationary cycling than sedentary patients with the same disease, alongside lower apathy and bradykinesia scores 2.
  • A review of rodent studies describes exercise as producing a sensitised, “hyperdopaminergic” state in striatal circuits that can shift how the brain responds to later stressful or aversive events 4.

What the evidence does not support

  • A PET study using [11C]raclopride in 12 healthy regular exercisers found no significant change in striatal D2 receptor availability, a marker of synaptic dopamine, after 30 minutes of vigorous treadmill running, despite heart rates rising by an average of 143% 1.
  • A randomised, placebo-controlled trial in 63 people found that the euphoria and reduced anxiety of a runner’s high were unaffected by blocking opioid receptors with naltrexone, while plasma endocannabinoid levels rose with running — evidence for an endocannabinoid mechanism, not a dopamine or classic endorphin one 3.

What we know

  • A PET study of 12 healthy regular exercisers found no significant change in striatal dopamine D2 receptor availability after 30 minutes of treadmill running 1.
  • A double-blind, placebo-controlled trial found that the euphoria and reduced anxiety of a runner’s high did not depend on opioid signalling, while plasma endocannabinoids rose with running 3.
  • A small PET study in Parkinson’s patients found greater dopamine release after exercise in habitual exercisers than in sedentary patients with the same disease 2.
  • Rodent studies describe regular exercise producing a sensitised, “hyperdopaminergic” state in striatal circuits 4.

What we don’t know

  • Whether longer, more intense, or more sustained running programmes (rather than one 30-minute session) produce a measurable dopamine change in healthy human runners has not been directly tested with PET.
  • Whether the caudate dopamine release seen in exercising Parkinson’s patients would also be found in healthy runners, or is specific to a dopamine-depleted brain compensating for exercise, is unknown.

How sure are we?

  1. Very confident
  2. Reasonably confident
  3. Uncertain
  4. Very uncertain

Uncertain. The single direct human PET test found no acute effect 1, and the only positive human finding comes from a different, diseased population 2, so the human picture for running specifically is thin.

Confidence describes how settled the answer on this page is, not how important the topic is. It can change as new research is published.

What would change the answer?

The evidence that is currently missing:

  • PET studies testing longer, more intense or sustained running programmes rather than one session
  • PET studies in healthy runners rather than only in Parkinson’s patients
  • Studies testing whether rodent hyperdopaminergic adaptations occur in human regular exercisers

Common misconception

Misconception

Running gives your brain a hit of dopamine, which is why it feels good and why people get hooked on it.

What the evidence says

The one direct human PET test of dopamine after running found no significant change, and the well-known “runner’s high” feeling has been tied experimentally to endocannabinoids, not dopamine 13.

Key studies

  • PET [11C]raclopride study in 12 healthy regular exercisers; no significant change in striatal D2 receptor availability after 30 minutes of treadmill running.1
  • PET and fMRI study comparing 8 habitual exercisers with Parkinson’s disease to 9 sedentary patients; greater caudate dopamine release after stationary cycling in the exercising group, with lower apathy and bradykinesia.2
  • Double-blind, randomised, placebo-controlled trial (n=63) testing whether opioid blockade (naltrexone) prevents runner’s-high euphoria and anxiety reduction; it did not, while plasma endocannabinoids rose with running.3
  • Narrative review of rodent studies on exercise-induced adaptations in dopamine circuits, describing a sensitised, “hyperdopaminergic” striatal state after regular exercise.4

The bottom line

The direct human evidence that running raises brain dopamine is currently thin, and the one PET study that tested it found no change. The runner’s high itself appears to run on a different brain chemical entirely.

The Brief

Understand your brain a little better each week.

Join The Brief from dopamine.co.uk. Free. No spam, no supplements, no selling your address. Unsubscribe in one click.

Sign-up opening soon

References

  1. 1. Wang GJ, et al. PET studies of the effects of aerobic exercise on human striatal dopamine release. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2000. PMID 10945526.
  2. 2. Sacheli MA, et al. Habitual exercisers versus sedentary subjects with Parkinson’s Disease: Multimodal PET and fMRI study. Movement disorders : official journal of the Movement Disorder Society. 2018. PMID 30376184. doi:10.1002/mds.27498
  3. 3. Siebers M, et al. Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. Psychoneuroendocrinology. 2021. PMID 33582575. doi:10.1016/j.psyneuen.2021.105173
  4. 4. Greenwood BN The role of dopamine in overcoming aversion with exercise. Brain research. 2019. PMID 30171838. doi:10.1016/j.brainres.2018.08.030